Skip to Content

A Treatment Option for the Prevention of Migraine in Adults

Jun 20, 2023
2:00 pm EDT
Presented by Abbvie
Register Now Registration takes place at a third-party website.

About This Webinar

Migraine is a complex, chronic disease that results in significant patient and economic burden. Migraine ranks second worldwide in terms of years lost due to disability. Direct annual all cause health care costs for a migraine patient is over twice that of a non-migraine patient. Indirect costs from the impact of the disease on a patient’s ability to function (absenteeism and presenteeism) total over $35B annually. Therefore, it is important to appropriately manage a person with migraine who experiences greater than 4 attacks a month (or severe disability from at least two attacks a month) and may benefit from preventive therapy.

One of the main goals of preventive therapy is to improve function and reduce disability. Utilizing a stratified care approach to preventive migraine treatment is key to accomplish this goal. The objective for this webinar is to review the migraine disease state, with an emphasis on the impact on patient function and quality of life, and outline the atogepant clinical data for the preventive treatment of migraine.

Attendees Will Learn About

  • The stratified care approach to preventive treatment of migraine
  • Migraine CGRP Treatment landscape (current and future)
  • Atogepant migraine expanded indication


Carolyn Bernstein, MD

Assistant Professor of Neurology

Harvard Medical School

Carolyn Bernstein, MD, FAHS, is currently the Lavine Family Distinguished Chair in Neurology at Brigham and Women’s Hospital and an Assistant Professor of Neurology at Harvard Medical School. She has won Harvard Medical School awards for teaching and for humanism in medicine, and was also awarded the National Headache Foundation’s Healthcare Provider of the Year award in 2008.

Learn more about Carolyn Bernstein, MD